Assessment of anti‑reflux treatment on pulmonary ventilation function and inflammatory cytokines in patients with stable chronic obstructive pulmonary disease combined with gastroesophageal reflux

Liu,Hang

doi:10.3892/etm.2018.6077

Assessment of anti‑reflux treatment on pulmonary ventilation function and inflammatory cytokines in patients with stable chronic obstructive pulmonary disease combined with gastroesophageal reflux

Authors:
- Hang Liu
View Affiliations

Affiliations: Department of Respiratory Medicine, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Autonomous Region 530022, P.R. China
Published online on: April 18, 2018 https://doi.org/10.3892/etm.2018.6077
Pages: 5528-5536

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Compelling evidence has demonstrated that systemic inflammation among patients with stable chronic obstructive pulmonary disease (COPD) is linked with increased levels of inflammatory cytokines. The aim of the present study was to investigate the effects associated with anti‑reflux treatment on pulmonary ventilation function and inflammatory cytokines in patients with stable COPD and gastroesophageal reflux (GER). One hundred and thirty‑six stable COPD and GER patients were recruited for the study and randomly designated into the routine treatment and the anti GER groups. Six months prior to and after treatment, pulmonary ventilation function, 6‑min walk distance (6MWD) and times of acute exacerbation of COPD (AECOPD) were recorded. The levels of inflammatory cytokines IL‑13, IL‑18, transforming growth factor‑β1 (TGF‑βl) and tumor necrosis factor‑α (TNF‑α) in the sputum were detected by ELISA. BODE indexes, including body mass index, obstruction, dyspnea and exercise, were analyzed in order to evaluate patient prognoses. In comparison with the routine treatment group, patients in the anti‑GER group displayed improved pulmonary ventilation function, increased 6MWD as well as decreases in AECOPD, levels of IL‑13, IL‑18, TGF‑βl and TNF‑α in the sputum and BODE index 6 months after treatment. The results obtained suggested a correlation between the BODE indexes after treatment and the course of disease as well as the frequency of exacerbation. The key findings of the study suggested that conventional treatment combined with anti‑reflux treatment could effectively improve pulmonary ventilation function, while acting to decrease the levels of inflammatory cytokines and improve the prognosis of patients with stable COPD along with GER.

View Figures

View References

1	Delzell JE Jr: Common lung conditions: Chronic obstructive pulmonary disease. FP Essent. 409:23–31. 2013.PubMed/NCBI
2	Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 187:347–365. 2013. View Article : Google Scholar : PubMed/NCBI
3	Parameswaran Iyer G and Murphy TF: Chronic obstructive pulmonary disease: Role of bacteria and updated guide to antibacterial selection in the older patient. Drugs Aging. 26:985–995. 2009. View Article : Google Scholar : PubMed/NCBI
4	Lee H, Kim J and Tagmazyan K: Treatment of stable chronic obstructive pulmonary disease: The GOLD guidelines. Am Fam Physician. 88(655–663): 663B–F. 2013.
5	Gan WQ, Man SF, Senthilselvan A and Sin DD: Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis. Thorax. 59:574–580. 2004. View Article : Google Scholar : PubMed/NCBI
6	Casanova C, Baudet JS, del Valle Velasco M, Martin JM, Aguirre-Jaime A, de Torres JP and Celli BR: Increased gastro-oesophageal reflux disease in patients with severe COPD. Eur Respir J. 23:841–845. 2004. View Article : Google Scholar : PubMed/NCBI
7	Rogha M, Behravesh B and Pourmoghaddas Z: Association of gastroesophageal reflux disease symptoms with exacerbations of chronic obstructive pulmonary disease. J Gastrointestin Liver Dis. 19:253–256. 2010.PubMed/NCBI
8	Liang BM and Feng YL: Association of gastroesophageal reflux disease symptoms with stable chronic obstructive pulmonary disease. Lung. 190:277–282. 2012. View Article : Google Scholar : PubMed/NCBI
9	Wang AJ, Liang MJ, Jiang AY, Lin JK, Xiao YL, Peng S, Chen J, Wen WP and Chen MH: Gastroesophageal and laryngopharyngeal reflux detected by 24-hour combined impedance and pH monitoring in healthy Chinese volunteers. J Dig Dis. 12:173–180. 2011. View Article : Google Scholar : PubMed/NCBI
10	Yeh AM and Golianu B: Integrative treatment of reflux and functional dyspepsia in children. Children (Basel). 1:119–133. 2014.PubMed/NCBI
11	Ingebrigtsen TS, Marott JL, Vestbo J, Nordestgaard BG, Hallas J and Lange P: Gastro-esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease. Respirology. 20:101–107. 2015. View Article : Google Scholar : PubMed/NCBI
12	Benson VS, Müllerová H, Vestbo J, Wedzicha JA, Patel A and Hurst JR: Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators: Associations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease. Respir Med. 109:1147–1154. 2015. View Article : Google Scholar : PubMed/NCBI
13	Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, et al: Endoscopic assessment of oesophagitis: Clinical and functional correlates and further validation of the Los Angeles classification. Gut. 45:172–180. 1999. View Article : Google Scholar : PubMed/NCBI
14	Holub JL, Silberg DG, Michaels LC, Williams JL, Morris CD and Eisen G: Acid-related upper endoscopy findings in patients with diabetes versus non-diabetic patients. Dig Dis Sci. 55:2853–2859. 2010. View Article : Google Scholar : PubMed/NCBI
15	Kumbhari V, Familiari P, Bjerregaard NC, Pioche M, Jones E, Ko WJ, Hayee B, Cali A, Ngamruengphong S, Mion F, et al: Gastroesophageal reflux after peroral endoscopic myotomy: A multicenter case-control study. Endoscopy. 49:634–642. 2017. View Article : Google Scholar : PubMed/NCBI
16	Calik-Kutukcu E, Savci S, Saglam M, Vardar-Yagli N, Inal-Ince D, Arikan H, Aribas Z, Ozer O, Bosnak-Guclu M and Coplu L: A comparison of muscle strength and endurance, exercise capacity, fatigue perception and quality of life in patients with chronic obstructive pulmonary disease and healthy subjects: A cross-sectional study. BMC Pulm Med. 14:62014. View Article : Google Scholar : PubMed/NCBI
17	Williams JE, Green RH, Warrington V, Steiner MC, Morgan MD and Singh SJ: Development of the i-BODE: Validation of the incremental shuttle walking test within the BODE index. Respir Med. 106:390–396. 2012. View Article : Google Scholar : PubMed/NCBI
18	Kim J, Lee JH, Kim Y, Kim K, Oh YM, Yoo KH, Rhee CK, Yoon HK, Kim YS, Park YB, et al: Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: A national cross-sectional cohort study. BMC Pulm Med. 13:512013. View Article : Google Scholar : PubMed/NCBI
19	Gadel AA, Mostafa M, Younis A and Haleem M: Esophageal motility pattern and gastro-esophageal reflux in chronic obstructive pulmonary disease. Hepatogastroenterology. 59:2498–2502. 2012.PubMed/NCBI
20	Takada K, Matsumoto S, Kojima E, Iwata S, Okachi S, Ninomiya K, Morioka H, Tanaka K and Enomoto Y: Prospective evaluation of the relationship between acute exacerbations of COPD and gastroesophageal reflux disease diagnosed by questionnaire. Respir Med. 105:1531–1536. 2011. View Article : Google Scholar : PubMed/NCBI
21	Sakae TM, Pizzichini MM, Teixeira PJ, Silva RM, Trevisol DJ and Pizzichini E: Exacerbations of COPD and symptoms of gastroesophageal reflux: A systematic review and meta-analysis. J Bras Pneumol. 39:259–271. 2013.(In English, Portuguese). View Article : Google Scholar : PubMed/NCBI
22	Pacheco-Galván A, Hart SP and Morice AH: Relationship between gastro-oesophageal reflux and airway diseases: The airway reflux paradigm. Arch Bronconeumol. 47:195–203. 2011. View Article : Google Scholar : PubMed/NCBI
23	Phulpoto MA, Qayyum S, Rizvi N and Khuhawar SM: Proportion of gastroesophageal reflux symptoms in patients with chronic obstructive pulmonary disease. J Pak Med Assoc. 55:276–279. 2005.PubMed/NCBI
24	Oh CK, Geba GP and Molfino N: Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma. Eur Respir Rev. 19:46–54. 2010. View Article : Google Scholar : PubMed/NCBI
25	Hashimoto K, Sheller JR, Morrow JD, Collins RD, Goleniewska K, O'Neal J, Zhou W, Ji S, Mitchell DB, Graham BS and Peebles RS Jr: Cyclooxygenase inhibition augments allergic inflammation through CD4-dependent, STAT6-independent mechanisms. J Immunol. 174:525–532. 2005. View Article : Google Scholar : PubMed/NCBI
26	Crosby LM and Waters CM: Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol. 298:L715–L731. 2010. View Article : Google Scholar : PubMed/NCBI
27	van de Veerdonk FL, Netea MG, Dinarello CA and Joosten LA: Inflammasome activation and IL-1β and IL-18 processing during infection. Trends Immunol. 32:110–116. 2011. View Article : Google Scholar : PubMed/NCBI
28	Dima E, Koltsida O, Katsaounou P, Vakali S, Koutsoukou A, Koulouris NG and Rovina N: Implication of Interleukin (IL)-18 in the pathogenesis of chronic obstructive pulmonary disease (COPD). Cytokine. 74:313–317. 2015. View Article : Google Scholar : PubMed/NCBI
29	Johnson PR, Burgess JK, Ge Q, Poniris M, Boustany S, Twigg SM and Black JL: Connective tissue growth factor induces extracellular matrix in asthmatic airway smooth muscle. Am J Respir Crit Care Med. 173:32–41. 2006. View Article : Google Scholar : PubMed/NCBI
30	von Haehling S, Hopkinson NS, Polkey MI, Niethammer M, Anker SD and Genth-Zotz S: Elevated TNFalpha production in whole blood in patients with severe COPD: The potential link to disease severity. Wien Klin Wochenschr. 121:303–308. 2009. View Article : Google Scholar : PubMed/NCBI
31	Eagan TM, Ueland T, Wagner PD, Hardie JA, Mollnes TE, Damås JK, Aukrust P and Bakke PS: Systemic inflammatory markers in COPD: Results from the Bergen COPD cohort study. Eur Respir J. 35:540–548. 2010. View Article : Google Scholar : PubMed/NCBI
32	Shahabi S, Rasmi Y, Jazani NH and Hassan ZM: Protective effects of Helicobacter pylori against gastroesophageal reflux disease may be due to a neuroimmunological anti-inflammatory mechanism. Immunol Cell Biol. 86:175–178. 2008. View Article : Google Scholar : PubMed/NCBI
33	Polkey MI, Spruit MA, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PM, Tal-Singer R, Agusti A, Bakke PS, et al: Six-minute-walk test in chronic obstructive pulmonary disease: Minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med. 187:382–386. 2013. View Article : Google Scholar : PubMed/NCBI
34	Hernandes NA, Wouters EF, Meijer K, Annegarn J, Pitta F and Spruit MA: Reproducibility of 6-minute walking test in patients with COPD. Eur Respir J. 38:261–267. 2011. View Article : Google Scholar : PubMed/NCBI